Transformation of Indigenous Primary Healthcare Delivery (FORGE AHEAD)

June 9, 2020 updated by: Lawson Health Research Institute

Transformation of Indigenous Primary Healthcare Delivery (FORGE AHEAD): Community-driven Innovations and Strategic Scale-up Toolkits

Context: Indigenous peoples experience higher prevalence rates of diabetes and worse health outcomes compared to the general population because of a wide array of factors: social determinants of health, lifestyle, genetic susceptibility, and historic-political and psycho-social factors. Barriers to care that are unique to First Nations communities exacerbate the problem with fragmented healthcare, poor chronic disease management, healthcare staff turnover, and limited, or non-existent, surveillance.

Program: The TransFORmation of IndiGEnous PrimAry HEAlthcare Delivery (FORGE AHEAD) research program aims to develop and evaluate community-driven, culturally relevant, primary healthcare models that enhance chronic disease prevention and management in First Nations communities in Canada. Participants will consist of Indigenous community and clinic team members that will take part in multiple interrelated projects including community profiling, readiness consultations, diabetes registry and surveillance, and quality improvement workshops and action periods.

Design: This mixed-method pre-post observational study will capture: 1) diabetes clinical process and outcomes measures, 2) details about community-driven innovations, and 3) knowledge about the experience and cost of attempting to improve primary delivery in individual Indigenous communities.

Intervention/Instrument: Survey, literature review, 15 month intervention (readiness consultations, implementation and maintenance of a registry and surveillance system, community and clinic focused quality improvement workshops), interviews.

Measures: Primary- mean A1C of patients with diabetes (A1C ≥ 8.0% at baseline); Secondary-clinical process and outcome measures, change in stage of readiness, description of participation and innovation facilitators and barriers.

Policy Implications: The outcomes of this research program have the potential to significantly affect future policy decisions pertaining to chronic disease care in First Nations communities. Policy recommendations will be made to help support Indigenous communities in adopting successful innovations to help address issues related to diabetes and other chronic illnesses. The community-driven innovations developed in FORGE AHEAD and the subsequent policy decisions may enhance chronic disease prevention and management for Indigenous peoples across the country.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • London, Ontario, Canada, N6G2M1
        • Centre for Studies in Family Medicine, Western University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Indigenous community and clinic team members

Description

Community members

Inclusion Criteria:

  • 18 years of age or older
  • on-reserve residents of participating Indigenous community partners

Exclusion Criteria:

  • less than 18 years of age
  • off-reserve residents of participating or non-participating Indigenous community partners

Clinic team members

Inclusion Criteria:

  • Health centers of participating Indigenous community partners
  • Current type 2 diabetes mellitus registry and surveillance system

Exclusion Criteria:

  • Health centers of non-participating Indigenous community partners
  • No registry or surveillance system

Diabetes Registry

Inclusion Criteria:

  • adults (age≥ 18 years) with type 2 diabetes and most recent HbA1C≥ 8.0%

Exclusion Criteria:

  • gestational diabetes, type 1 diabetes, or severe co-morbidity associated with life expectancy <6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
11 First Nations Community and Clinical Teams
11 Community & Clinical Teams in each First Nation community participated in the intervention.
Community and Clinical Teams engaged in implementing Quality Improvement initiatives to improve diabetes prevention and management within their First Nations community and clinic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measures: baseline (12 months prior to the start of the program)
repeated measures: baseline (12 months prior to the start of the program)
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measures: 6 month after program start date
repeated measures: 6 month after program start date
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measures: 12 month after program start date
repeated measures: 12 month after program start date
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measure: 18 months after program start
repeated measure: 18 months after program start
mean HbA1C of patients with diabetes (A1C ≥ 8.0% at baseline)
Time Frame: repeated measure: 24 months after program start
repeated measure: 24 months after program start

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2014

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

March 31, 2020

Study Registration Dates

First Submitted

July 30, 2014

First Submitted That Met QC Criteria

September 8, 2014

First Posted (Estimate)

September 9, 2014

Study Record Updates

Last Update Posted (Actual)

June 11, 2020

Last Update Submitted That Met QC Criteria

June 9, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes Mellitus

Clinical Trials on Quality Improvement

3
Subscribe